These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 930175)

  • 1. [Type distribution of hyperlipoproteinemias in 645 diabetics].
    Möricke R; Marek H; Winiecki P; Mochow P; Bindseil S; Reichert E
    Z Gesamte Inn Med; 1977 Jun; 32(11):suppl 171-4. PubMed ID: 930175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetes and hyperlipoproteinaemias (author's transl)].
    Wahl P; Hasslacher C; Vollmar J
    Dtsch Med Wochenschr; 1974 Oct; 99(43):2158-60, 2163-5. PubMed ID: 4430277
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum lipoproteins and coronary disease in diabetes. Changes in the lipoprotein pattern in relation to the type of antidiabetic therapy].
    Sommariva D; Scotti L; Zanaboni L; Massaroli C; Bonfiglioli D; Negrati M; Micossi P; Fasoli A
    Minerva Med; 1983 Dec; 74(47-48):2853-9. PubMed ID: 6361618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetes mellitus under 30 years of age. Results of 18 years experience with oral treatment (author's transl)].
    Mirouze J; Cartry E
    Diabete Metab; 1975 Jun; 1(2):113-8. PubMed ID: 1234068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clofibrate treatment of diabetics with hyperproteinemias (author's transl)].
    Jung W; Kremer GJ; Müller D
    MMW Munch Med Wochenschr; 1975 Oct; 117(44):1783-6. PubMed ID: 171564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Improvement in diabetes control by treatment with bezafibrate].
    Rüth E; Vollmar J
    Dtsch Med Wochenschr; 1982 Oct; 107(39):1470-3. PubMed ID: 6749468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of HDL cholesterol in diabetes mellitus in relation to various types of therapy].
    Floriani M; Spadoni M
    Quad Sclavo Diagn; 1984 Jun; 20(2):236-43. PubMed ID: 6396678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of insulin therapy on lipoprotein concentrations in secondary sulfonylurea treatment failures in menopause].
    Schauer UJ
    Z Gesamte Inn Med; 1988 Dec; 43(23):666-9. PubMed ID: 3149825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HDL-cholesterol in diabetes mellitus. Analysis of type of diabetes, therapy, duration of disease and metabolic control (author's transl)].
    Prager R; Schernthaner G; Müller MM
    Wien Klin Wochenschr; 1980 Oct; 92(19):672-7. PubMed ID: 7008366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of decreased serum adiponectin for type IIb hyperlipidaemia and increased cholesterol levels of very-low-density lipoprotein in type II diabetic patients.
    Yoshida H; Hirowatari Y; Kurosawa H; Tada N
    Clin Sci (Lond); 2005 Sep; 109(3):297-302. PubMed ID: 15907189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma fibrinogen in diabetes mellitus.
    De Silva SR; Shawe JE; Patel H; Cudworth AG
    Diabete Metab; 1979 Sep; 5(3):201-6. PubMed ID: 499635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma HDL in non-insulin-dependent diabetes and the effect of various types of treatment.
    Shoukry M; Jayyab AK
    Atherosclerosis; 1983 Dec; 49(3):333-8. PubMed ID: 6661271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid metabolism in pregnancy. I. Changes in lipoprotein triglyceride and cholesterol in normal pregnancy and the effects of diabetes mellitus.
    Knopp RH; Warth MR; Carrol CJ
    J Reprod Med; 1973 Mar; 10(3):95-101. PubMed ID: 4348501
    [No Abstract]   [Full Text] [Related]  

  • 16. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of biguanides on insulin sensitivity of maturity onset diabetics (author's transl)].
    Lisch HJ; Sailer S; Braunsteiner H
    Wien Klin Wochenschr; 1980 Apr; 92(8):266-9. PubMed ID: 6996339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term effect of buformin, a biguanide, on insulin sensitivity, soluble fraction of tumor necrosis factor receptor and serum lipids in overweight patients with type 2 diabetes mellitus.
    Ohara S; Komatsu R; Matsuyama T
    Diabetes Res Clin Pract; 2004 Nov; 66(2):133-8. PubMed ID: 15533580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [High-density lipoprotein cholesterol and the atherogenic index in patients with different types of hyperlipoproteinemias].
    Apostolov I; Naumova R; Balabanski L; Goranov I
    Vutr Boles; 1983; 22(3):70-4. PubMed ID: 6649586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood lactate and biguanide therapy: comparison between phenformin, metformin and buformin in 408 senile diabetics].
    Bruneder H; Klein HJ
    Acta Med Austriaca; 1978; 5(3):88-90. PubMed ID: 752220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.